ARCA Biopharma Inc ABIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
4.00quote price arrow up+0.28 (+7.53%)
Volume
165,481
52 week range
1.56 - 4.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.00
  • 52 Week High4.00
  • 52 Week High Date05/16/24
  • 52 Week Low1.56
  • 52 Week Low Date01/19/24

Key Stats

  • Market Cap58.029M
  • Shares Out14.51M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change118.82

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.00
  • 52 Week High4.00
  • 52 Week High Date05/16/24
  • 52 Week Low1.56
  • 52 Week Low Date01/19/24
  • Market Cap58.029M
  • Shares Out14.51M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change118.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.42
  • P/E (TTM)-9.63
  • Fwd P/E (NTM)-0.45
  • EBITDA (TTM)-7.968M
  • ROE (TTM)-15.87%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ARCA Biopharma Inc

 

Profile

MORE
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target...
Robert Conway CPA
Independent Chairman of the Board
Thomas Keuer
President, Principal Executive Officer, Chief Operating Officer
C. Jeffrey Dekker CPA
Chief Financial Officer
Address
10170 Church Ranch Way, Suite 100
Westminster, CO
80021
United States

Top Peers

SYMBOLLASTCHG%CHG
RVPH
Reviva Pharmaceuticals Holdings, Inc.
1.71UNCHUNCH
CKPT
Checkpoint Therapeutics Inc
1.78+0.15+9.20%
CLNN
Clene Inc.
0.3856+0.003+0.7841%
NXTC
NextCure Inc
1.65-0.01-0.60%
INTS
Intensity Therapeutics Inc
5.10+0.27+5.59%